Prospective phase II trial of levonorgestrel intrauterine device: nonsurgical approach for complex atypical hyperplasia and early-stage endometrial cancer is a research paper published in American Journal of Obstetrics and Gynecology (2020). On theSindex it has a DataRank of 4.0. It has been cited 125 times, with 100 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.725
From this paper's citation signal
Citation Network Contribution
3.3
From 89 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 100 citers.
University of Texas MD Anderson Cancer Center
Grant: 5 T32 CA101642 02
National Cancer Institute
Grant: 5P50CA098258-13
NCI NIH HHS
Grant: L30 CA189102
NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: P50 CA098258
NCI NIH HHS
Grant: K12 CA088084
NCI NIH HHS
Grant: T32 CA101642
Boehringer Ingelheim
Novartis
AstraZeneca
Bristol-Myers Squibb
Eisai
Genentech
Amgen
AbbVie
Janssen Pharmaceuticals
Clovis Oncology
National Institutes of Health
GOG Foundation
Merck
FWCI
6.25
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals